Expand the abbreviation into the actual composition
Stepan’s BTC 776 technical bulletin lists specific alkyl distributions and active composition, illustrating differences between commercial raw materials. Those values belong only to that product and are not universal BAC standards. Check the complete chemical description, identity and supplier specifications of the existing product. Avoid describing all benzalkonium chlorides as one fixed molecule or treating a single CAS number as sufficient evidence covering every commercial mixture.
Focus on the fields required for using the formulation
For formulators, raw-material activity, related composition, carrier and agreed impurities may affect subsequent product consistency. The actual formulation and quality system should determine mandatory controls rather than arbitrary copying from another company’s bulletin. Distinguish typical values from guaranteed specifications: typical values describe a reference condition, not an identical result promised for every batch.
Evaluate substitution trials within the final product
Basic raw-material analysis does not automatically establish unchanged finished-product stability, process behavior or permitted claims. Formulators should follow their procedures to assess whether substitution changes labeling, use or registration identity. Stepan raw-material bulletins distinguish formulation inputs from final-product responsibilities. Their application catalogs cannot establish approval of a self-formulated product for every listed environment.
Retain original definitions when comparing reports
When comparing new and old suppliers’ COAs, check each parameter’s name, method, unit and acceptance range; total quaternary ammonium activity is not necessarily one component’s concentration. Ask technical specialists to explain different chemical identities or alkyl distributions rather than deleting them to simplify the table. Mark additional information needed for incomparable items. Do not rewrite source documents merely to create apparent consistency and advance procurement.
Create reusable substitution review records
Record existing and candidate products, key differences, final-formulation validation and approval conclusions, citing the exact version in later purchasing. Clarify whether the inquiry seeks raw material for formulation or a ready-to-use water-treatment product to align delivery expectations. Limiting evidence to the actual product helps exclude obvious mismatches while preserving the possibility of substitution after further validation.
During raw-material substitution, check whether final-formulation documents specify a particular identity or composition range. Where requirements come from the customer’s quality system, suppliers should state actual capability rather than substitute another product’s composition table for confirmation. Include requirements in order attachments to avoid conforming raw material that does not suit the original formulation.
Explore further
If both products are BAC, can purchasing be based on active content alone?
This is not advisable; specific composition and final-use requirements still need checking.
Does a use listed in raw-material documentation mean the formulated product is approved for that use?
No. A formulated product needs its own applicability documentation.
References
This article draws on publicly available technical information. Third-party sources do not establish ENVO product approvals, field testing or project experience. Confirm each use against actual supply documents and site conditions.